Insight on Pharmaceuticals and Healthcare in North America

The following industries match your search criteria:

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Click here to sort results by relevance. Click on heading titles to sort results by different field.

Type Product title / description Pub Price
Report
Report

Stakeholder Opinions: Hepatocellular cancer

Stakeholder Opinions: Hepatocellular Cancer discusses issues in the treatment of hepatocellular cancer, highlighting potential target populations for drug developers, treatment limitations and unmet needs, and an overview of the current pipeline.

Published By Datamonitor
01 Dec 2010 $3800
Buy
Report
Report

Forecast Insight: Depression - High rewards for novel and adjunctive therapies in treatment-resistant depression

Analysis of the current and future market for drugs treating depression. Includes sales forecasts to 2019 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) of key marketed brands, generics, and pipeline products.

Published By Datamonitor
09 Dec 2010 $15200
Buy
Report
Report

Pipeline and Commercial Insight: Psoriasis - Established brands challenged by new therapies

Overview of the current and future psoriasis market, providing in-depth analysis of recent events in the market together with 10 year indication specific sales forecasts and profiles of key brands and pipeline products across the seven major markets.

Published By Datamonitor
10 Dec 2010 $15200
Buy
Report
Report

Stakeholder Opinions: Tropical Diseases - Dengue, Japanese encephalitis and West Nile virus – Increasing attention for neglected diseases

This report explores key issues in dengue, Japanese encephalitis and West Nile infection. It contains an analysis of epidemiological trends, assessment of marketed vaccines and discusses the pipeline for vaccines and virus-specific therapeutics.

Published By Datamonitor
14 Dec 2010 $3800
Buy
Report
Report

Commercial Insight: Disease Modification in Rheumatoid Arthritis – Market awaits game changing therapies and strategies

Coverage of disease-modifying drugs in the seven major rheumatoid arthritis markets, including indication-specific 10-year forecasts (using both sales and patient-based approaches), detailed brand profiling and an in-depth patient-based case study.

Published By Datamonitor
15 Dec 2010 $15200
Buy
Report
Report

Pipeline and Commercial Insight: Urinary Incontinence - Marketing investment and niche positioning are key strategies for success

Full analysis of the future urinary incontinence market. Includes sales forecasts to 2019 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) for key marketed brands, generics, and pipeline products.

Published By Datamonitor
15 Dec 2010 $15200
Buy
Report
Report

Stakeholder Insight: COPD in Emerging Markets (Brazil, India, China, US) - Key differences in treatment despite standardized guidelines

Datamonitor's survey of 300 respiratory experts in Brazil, India, China and the US addresses increased interest in COPD in the emerging markets. The US is included as a benchmark, providing unique insight and comparisons of COPD market dynamics.

Published By Datamonitor
22 Dec 2010 $15200
Buy
Report
Report

Stakeholder Insight: Major Depressive Disorder - Gaining traction among physicians is crucial in an SSRI-dominated market

Primary research-based analysis of the major depressive disorder market, based on a survey of 180 psychiatrists in the US, Japan, and EU. Includes epidemiology, patient segmentation, treatment trends, perception of key brands, and patient outcomes.

Published By Datamonitor
23 Dec 2010 $15200
Buy
Report
Report

Pharmaceutical Key Trends 2011: Biosimilar Market Overview

Comparative analysis of biosimilar drivers and resistors, key players, market access, pricing, and future launches across multiple markets including: the US, Japan, France, Germany, Italy, Spain, the UK, Australia, Brazil, Russia, India and China.

Published By Datamonitor
23 Feb 2011 $3800
Buy
Report
Report

Pharmaceutical Key Trends 2011: Healthcare System and Drug Regulatory Overview

Analysis of healthcare expenditure, reforms, pricing and reimbursement and drug regulation across multiple markets including: the US, Japan, France, Germany, Italy, Spain, the UK, Australia, Brazil, Russia, India and China.

Published By Datamonitor
25 Mar 2011 $3800
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.